Netherlands-based cultivated meat company Meatable has announced the acquisition of the cultivated meat platform of UK biotech company Uncommon Bio. The deal includes key technology, intellectual property assets, high-performing cell lines, and expert staff.
Meatable claims that it now operates the only true multi-platform cultivated meat technology offering, following the integration of Uncommon Bio’s non-GMO mRNA reprogramming and saRNA differentiation technologies. These capabilities, combined with Meatable’s use of the patented opti-ox™ system, will allow the company to accelerate time to market, navigate regulatory pathways worldwide, and adapt to consumer and cultural preferences.
“I’m incredibly proud of what we’ve built at Uncommon Bio, a legacy of innovation and bold thinking in cultivated meat,” said Benjamina Bollag, CEO of Uncommon. “After deciding to focus on therapeutics, we wanted to find the best home for our technology, and it’s exciting to see Meatable carry our work forward and apply it at scale. I look forward to continuing our collaboration and watching their continued success and global impact in the years ahead.”
“More than a strategic step”
Meatable has already developed cultivated beef and pork, but says it is now positioned to expand rapidly across species, markets, and consumer segments. The addition of Uncommon’s technology could accelerate product development for chicken, lamb, and high-flavor breeds, while its non-GMO status and regulatory-ready dossier could support faster approval in several regions.
Meatable says it is now forming partnerships across the supply chain with the aim of complementing, rather than replacing, traditional livestock producers. The company received investment from the leading Thai meat company Betagro in 2024, and hired two meat industry veterans earlier this year.
“This acquisition is more than a strategic step — it sets a new standard for cultivated meat production,” said Jeff Tripician, CEO of Meatable. “By combining two highly complementary platforms, Meatable is now equipped to reliably deliver high-quality cultivated meat at a global scale. This enables us to support the meat industry with a stable, secure, and future-proof supply of species like pork, beef, lamb, and poultry, ensuring business continuity and resilience in the face of increasingly uncertain times.”
